Williams Timothy — SEC insider filings

SEC reporting owner CIK 1748392. 19 insider filings on record with FilingPulse; latest filed 2026-11-16.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2020-08-17 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Vanda Pharmaceuticals Inc. (VNDA)SVP & General Counsel17—16 legs · 151,749 sh · $1,466,07810
GERON CORP (GERN)EVP and Chief Legal Officer21 leg · 12,000 sh · $11,280—1

Insider filings — Williams Timothy

FiledFormIssuerReported transactionsSource
2026-11-164GERON CORP (GERN)Purchase (P): 12,000 @ $0.94EDGAR
2026-04-144GERON CORP (GERN)Grant/award (A): 2,500,000 (derivative) @ $0EDGAR
2026-03-044Vanda Pharmaceuticals Inc. (VNDA)Sale (S): 42,434 @ $8.27EDGAR
2026-02-194Vanda Pharmaceuticals Inc. (VNDA)Grant/award (A): 125,000 @ $0EDGAR
2025-03-044Vanda Pharmaceuticals Inc. (VNDA)Tax withholding (F): 26,941 @ $4.76EDGAR
2025-02-204Vanda Pharmaceuticals Inc. (VNDA)Grant/award (A): 125,000 @ $0EDGAR
2024-03-064Vanda Pharmaceuticals Inc. (VNDA)Sale (S): 8,147 @ $4.41 · Sale (S): 8,941 @ $4.18EDGAR
2024-02-214Vanda Pharmaceuticals Inc. (VNDA)Grant/award (A): 125,000 @ $0EDGAR
2023-06-154Vanda Pharmaceuticals Inc. (VNDA)Sale (S): 14,600 @ $6.56EDGAR
2023-03-064Vanda Pharmaceuticals Inc. (VNDA)Sale (S): 8,437 @ $6.24 · Sale (S): 8,301 @ $6.25EDGAR
2023-02-214Vanda Pharmaceuticals Inc. (VNDA)Grant/award (A): 32,700 @ $0 · Grant/award (A): 77,500 (derivative) @ $0EDGAR
2022-12-164Vanda Pharmaceuticals Inc. (VNDA)Sale (S): 8,000 @ $7.01EDGAR
2022-08-174Vanda Pharmaceuticals Inc. (VNDA)Sale (S): 3,689 @ $10.42 · Sale (S): 4,611 @ $10.21EDGAR
2022-03-024Vanda Pharmaceuticals Inc. (VNDA)Grant/award (A): 32,700 @ $0 · Sale (S): 12,060 @ $11.09 · Grant/award (A): 77,500 (derivative) @ $0EDGAR
2021-08-174Vanda Pharmaceuticals Inc. (VNDA)Sale (S): 3,715 @ $16.15EDGAR
2021-03-084Vanda Pharmaceuticals Inc. (VNDA)Sale (S): 200 @ $17.88 · Sale (S): 5,400 @ $17.85EDGAR
2021-03-034Vanda Pharmaceuticals Inc. (VNDA)Sale (S): 11,856 @ $18.60 · Sale (S): 7,674 @ $18.54EDGAR
2021-02-264Vanda Pharmaceuticals Inc. (VNDA)Grant/award (A): 32,700 · Grant/award (A): 77,500 (derivative) @ $0EDGAR
2020-08-174Vanda Pharmaceuticals Inc. (VNDA)Sale (S): 3,684 @ $11.81EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1748392 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs